GoHealth, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the GoHealth, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, GoHealth, Inc. has recorded 112 reports. Market capitalisation: €8.9m. The latest transaction was reported on 17 August 2026 (Disposition). Among the most active insiders: CCP III Cayman GP Ltd.. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate GoHealth, Inc. Buy (bullish), based on 3 analysts. Average price target: US$5.17.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 August 2026
All Executives112 Thresholds0 Prospectus0 Other0
Declarations 112 total
● 10% Owner · Executives · 21 Jul 2026
4,179,850 shares Class A Common Stock SEC:0001104659-26-098010:0
● 10% Owner · Executives · 21 Jul 2026
4,179,850 shares Class A Common Stock SEC:0001104659-26-098011:0
● Chief Legal Officer · Executives · 21 Jul 2026
157,070 shares Class A Common Stock SEC:0001628280-26-049369:0
● Chief Executive Officer · Executives · 21 Jul 2026
1,347,396 shares Class A Common Stock SEC:0001628280-26-049365:0
● Chief Financial Officer · Executives · 21 Jul 2026
237,275 shares Class A Common Stock SEC:0001628280-26-049368:0
● Chief Financial Officer · Executives · 1 Nov 2025
12,725 shares @ US$3.96 100.0% of flow Class A Common Stock SEC:0001628280-25-048746:0
● Chief Operating Officer · Executives · 12 Sept 2025
5,545 shares @ US$4.98 7.1% of flow Class A Common Stock SEC:0001996571-25-000005:0
◆ Chief Executive Officer · Executives · 7 Aug 2025
218,551 shares 0Class A Common Stock SEC:0001808220-25-000063:0
● Chief Legal Officer · Executives · 5 May 2025
814 shares @ US$7.75 5.9% of flow Class A Common Stock SEC:0001808220-25-000041:0
● Chief Executive Officer · Executives · 10 Apr 2025
24,612 shares @ US$10.17 26.6% of flow Class A Common Stock SEC:0001808220-25-000039:0
◆ Chief Executive Officer · Executives · 3 Apr 2025
500,000 shares 0Class A Common Stock SEC:0001808220-25-000035:0
● Chief Operating Officer · Executives · 1 Apr 2025
8,317 shares @ US$12.39 31.1% of flow Class A Common Stock SEC:0001808220-25-000028:0
● Chief Legal Officer · Executives · 1 Apr 2025
4,884 shares @ US$12.39 59.4% of flow Class A Common Stock SEC:0001808220-25-000030:0
● Chief Executive Officer · Executives · 1 Apr 2025
24,611 shares @ US$12.39 33.8% of flow Class A Common Stock SEC:0001808220-25-000032:0
◆ Chief Financial Officer · Executives · 1 Apr 2025
100,000 shares 0Class A Common Stock SEC:0001808220-25-000026:0
● Chief Operating Officer · Executives · 21 Mar 2025
6,238 shares @ US$13.00 24.3% of flow Class A Common Stock SEC:0001808220-25-000019:0
● Chief Legal Officer · Executives · 21 Mar 2025
1,099 shares @ US$13.00 13.9% of flow Class A Common Stock SEC:0001808220-25-000021:0
◆ Chief Financial Officer · Executives · 1 Nov 2024
150,000 shares 0Class A Common Stock SEC:0001808220-24-000122:0
● Chief Operating Officer · Executives · 12 Sept 2024
5,545 shares @ US$8.28 13.5% of flow Class A Common Stock SEC:0001808220-24-000110:0
● Chief Operating Officer · Executives · 9 Aug 2024
4,159 shares @ US$9.08 11.3% of flow Class A Common Stock SEC:0001808220-24-000105:0
◆ Director · Executives · 12 Jun 2024
14,605 shares @ US$10.27 49.9% of flow Class A Common Stock SEC:0001808220-24-000087:0
◆ Director · Executives · 17 Jul 2024
9,906 shares @ US$13.98 100.0% of flow Class A Common Stock SEC:0001808220-24-000092:0
◆ Director · Executives · 12 Jun 2024
14,605 shares @ US$10.27 49.9% of flow Class A Common Stock SEC:0001808220-24-000091:0
◆ Director · Executives · 12 Jun 2024
24,342 shares @ US$10.27 49.9% of flow Class A Common Stock SEC:0001808220-24-000089:0
◆ Interim CFO · Executives · 14 Jun 2024
25,000 shares 0Class A Common Stock SEC:0001808220-24-000063:0
25 of 112 declarations
Load more (87 remaining) 关于 GoHealth, Inc. GoHealth, Inc.(股票代码:GOCO)是一家在美国纳斯达克(NASDAQ)上市的美国公司。对于国际投资者而言,GoHealth 最好被理解为一个专注于医疗保险的医疗保健分销和保险市场平台。该公司由 Clint Jones 和 Brandon Cruz 于 2001 年创立,最初是一个保险公司比较网站。随着时间的推移,它扩展到潜在客户开发、注册和消费者匹配能力,发展成为一个综合性的数字保险市场。GoHealth 的公司总部位于伊利哥芝加哥。
公司的核心业务围绕一个专有技术平台展开,该平台结合了机器学习算法、超过二十年的保险购买行为数据以及持牌人工代理。这种混合模式旨在帮助消费者找到符合其个人需求的健康计划,尤其是在医疗保险领域。GoHealth 将自己定位为一个以消费者为先的市场,强调计划的适用性、注册质量和续保经济性,而非纯粹的交易销售模式。历史上,该公司也积极参与《平价医疗法案》的注册,但近年来其战略重心已转向医疗保险。
从竞争角度来看,GoHealth 在一个分散但竞争激烈的环境中运营,其中包括保险经纪人、数字注册平台、潜在客户开发业务以及拥有自身分销渠道的保险公司。其相对优势在于专有技术、持牌销售支持以及处理大量注册的能力相结合。管理层持续关注提高转化效率、增强现有业务的经济效益以及优化消费者匹配。公司不支付股息,而是将其再投资于技术堆栈、持牌代理团队和 Encompass 平台。
近期发展表明公司正处于战略转型期。在最新的披露和盈利沟通中,GoHealth 强调了现金纪律、投资组合的持久性以及对医疗优势计划(Medicare Advantage)采取更具选择性的立场,同时保持在特殊需求计划(SNP)方面的领导地位。一个值得注意的战略举措是 2025 年推出 GoHealth Protect,将业务从医疗保险相关产品扩展到人寿保险,旨在解决临终和更广泛的财务保障需求。公司还在投资人工智能和运营效率,同时管理层表示,在仍然分散的行业中,整合机会仍是其长期战略框架的一部分。